Volume 14, Number 9—September 2008
Bluetongue Virus Serotype 8 Reemergence in Germany, 2007 and 2008
Highlight and copy the desired format.
|EID||Hoffmann B, Saßerath M, Thalheim S, Bunzenthal C, Strebelow G, Beer M, et al. Bluetongue Virus Serotype 8 Reemergence in Germany, 2007 and 2008. Emerg Infect Dis. 2008;14(9):1421-1423. https://dx.doi.org/10.3201/eid1409.080417|
|AMA||Hoffmann B, Saßerath M, Thalheim S, et al. Bluetongue Virus Serotype 8 Reemergence in Germany, 2007 and 2008. Emerging Infectious Diseases. 2008;14(9):1421-1423. doi:10.3201/eid1409.080417.|
|APA||Hoffmann, B., Saßerath, M., Thalheim, S., Bunzenthal, C., Strebelow, G., & Beer, M. (2008). Bluetongue Virus Serotype 8 Reemergence in Germany, 2007 and 2008. Emerging Infectious Diseases, 14(9), 1421-1423. https://dx.doi.org/10.3201/eid1409.080417.|
Reemerging bluetongue virus serotype 8 (BTV-8) in Germany was detected first in May 2007 in a sentinel cow and in February 2008 in an export heifer. Reemergence was confirmed by retesting the samples, experimental inoculation, fingerprinting analysis, and virus isolation. Overwintering of BTV-8 and continuous low-level infections are assumed.
Bluetongue virus (BTV) is a double-stranded RNA virus of the genus Orbivirus. BTV is transmitted to its hosts by the bite of Culicoides spp. midges. It causes a noncontagious, arthropod-borne disease of domestic and wild ruminants and camelids (1); disease can be serious, particularly in sheep (2–4). BTV had never been reported in any European country north of the Alps until August 2006, when outbreaks of BTV serotype 8 (BTV-8) were almost simultaneously discovered in the Netherlands, Belgium, Germany, and France (5–7). In 2006, a total of 893 cases were detected in Germany, but the source of initial virus introduction remains unknown. Subsequently, BTV-8 overwintered in the region, spread over most of the country, and led to almost 21,000 new cases in 2007 in Germany. BTV-8 infections spread to additional European countries, e.g., the United Kingdom, Switzerland, the Czech Republic, Denmark, and Spain (8–11).
To detect reemerging BTV-8 in Germany, a sentinel animal program was started in March 2007. Each month, the program tested 150 BTV-naive cattle per 2,025 km². Screening was performed by ≈30 regional laboratories located in the 16 federal states of Germany. Diagnostic testing was performed with commercially available BTV-blocking-ELISAs (Pourquier ELISA Bluetongue Serum, Institut Pourquier, Montpellier, France; Bluetongue Virus Antibody Test Kit, VMRD, Pullman, WA, USA: ID Screen Bluetongue Competition ELISA kit, ID Vet, Montpellier, France; INGEZIM BTV, INGENASA, Madrid, Spain) and validated BTV real-time PCRs (12; B. Hoffmann et al., unpub. data). All positive results were confirmed by the National Reference Laboratory for BTV at the Friedrich-Loeffler-Institut, Insel Riems.
On May 3, 2007, the first sentinel animal in the program (4-year-old Holstein Friesian cow, North-Rhine Westphalia, Germany) tested positive for BTV antibodies and genomes in a regional laboratory (Krefeld, Germany). This animal had tested negative for BTV on March 3 and April 3. After the positive test result, the original samples as well as new samples were transferred to the reference laboratory for further investigation. The sample collected on May 3 and all further samples of this animal tested positive by BTV ELISA as well as by BTV real-time reverse transcription–PCR (RT-PCR). According to Deutscher Wetterdienst, available from www.dwd.de, the daily temperatures in the region of North-Rhine Westphalia during this period ranged from minimums of 13.5°C to –1.3°C to maximums of 9.5°C to 28.1°C. A period with daily maximum temperatures >22°C from April 12 to April 16 suggests increased likelihood for activity of Culicoides. Similar prognoses for the reemergence of BTV-8 were published by Gloster et al. (13).
Samples taken on May 3 had positive ELISA titers of 8–16, and the cycle threshold (Ct) values of the real-time RT-PCR analysis were 25.6–27.9 (Figure, panel A). Therefore, new BTV-infection of a BTV-naive animal was suggested. To confirm the presence of infectious BTV, fresh EDTA-blood samples from the positive animal were experimentally injected into 2 bovids (40 mL intravenously and 10 mL subcutaneously). To mimic natural exposure by the bite of a midge, only 20 µL was injected subcutaneously into a 3rd bovid (Table). Both animals inoculated with 50 mL had positive real-time PCRs at day 2 postinoculation and reached Ct values of 22.9 and 24.3 by day 13. In contrast, the animal that had received the smaller volume remained negative for BTV antibodies and genomes. In addition, 1 of the animals that had received the larger volume showed late seroconversion according to BTV-blocking ELISA at day 30 (Table). Furthermore, the virus was typed as BTV-8 by using the BTV-8–specific primers BT8/101/F (14) and BT8/765/R (5′-CCACTGTCTATGTG CGTAA-3′, kindly provided by P. Mertens, Institute for Animal Health, Pirbright, UK) to amplify a 1,993-bp fragment of the VP2 gene by conventional RT-PCR (Figure, panel B). Testing of 80 contact animals from the same herd showed 38 antibody-positive cattle but no additional RT-PCR–positive case.
In February 2008, a 2-year-old Holstein Friesian heifer, destined for export from Schleswig-Holstein, tested positive for BTV antibodies and genomes during quarantine. Testing was done by a regional laboratory (Frankfurt Oder, Germany). Whereas a first blood sample collected on January 22, 2008, was negative according to real-time RT-PCR; a subsequent sample taken on February 15 was positive by real-time RT-PCR and had a Ct value of 25.13. Both test results were confirmed by the German National Reference Laboratory for BTV. For the positive EDTA blood sample, a Ct value of 25.1 and an ELISA inhibition value of 85.7% (positive >50%) were ascertained. Furthermore, fingerprinting analysis (StockMarks Cattle Genotyping Kit, Applied Biosystems, Foster City, CA, USA) confirmed that both the negative and the positive samples were from the same animal (data not shown). The meteorologic data from January 20 to February 15 showed unsuitable weather conditions for BTV replication in outdoor midges at the time of BTV transmission; daily minimum temperatures were 7.2°C to –6.3°C, and daily maximum temperatures 3.4°C–13.4°C. Finally, BTV was isolated after inoculation of Vero cell cultures with the real-time PCR-positive blood samples.
According to the dates of sampling and subsequent seroconversion, genome detection, and Ct values, 1 animal became infected during April 1–25, 2007, and the other became infected during January 20–February 12, 2008. According to meteorologic data, infection between April 15 and 25 is likely, whereas the suggested infection time in 2008 was not associated with weather suitable for BTV transmission. Therefore, we have drawn several conclusions. First, BTV-8 reemerged in Europe in 2007 and 2008 unexpectedly early. This timing makes it unlikely that a real vector-free period exists in northwest Europe. Second, the detection of both cases was fortuitous. Because of the low number of sentinel animals in 2007, or double-tested cattle destined for export in January and February 2008, substantially more new infections may have occurred in winter 2007 and early spring 2008. Therefore, overwintering of BTV-8 appears to be efficient, and under the climatic conditions of winter and spring 2007 and 2008 in Germany, continuous infections occurring at a low level must be assumed. However, the detailed mechanisms of overwintering remain unclear. In addition, the meterologic data connected to the early case in 2008 suggest indoor survival of infected midges. Third, sentinel animals proved to be useful for the early detection of recirculating virus. However, establishing and conducting an efficient sentinel program are complex and expensive endeavors, and, as shown in 2008, positive cases might be detected earlier by chance.
On the basis of our experience, we recommend that all samples that could represent new infections in a given region or season should be confirmed by a reference laboratory that as a minimum standard confirms identity of the origin of all samples. This step would avoid misleading interpretations due to, for example, a mix-up of samples or animals. Also, depending on future climate in the BTV-8–infected regions in 2008, the first BTV-8 case could indicate the need for early protection, especially of sheep and goats, by BTV-8–specific vaccination.
Dr Hoffmann is a veterinarian and senior scientist at the Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, in Insel Riems and head of the German National Reference Laboratory for BTV. His research interests focus on exotic animal diseases, diagnostics, pathogenesis studies, and development of new methods for molecular diagnostics.
We are grateful to Ulrike Polenz and Christian Korthase for their excellent technical assistance. In addition, we thank Thomas Mettenleiter for critically reading the manuscript.
The study was supported by the German Federal Ministry of Food, Agriculture, and Consumer Protection.
- Osburn BI. Bluetongue virus [review]. Vet Clin North Am Food Anim Pract. 1994;10:547–60.
- Mehlhorn H, Walldorf V, Klimpel S, Jahn B, Jaeger F, Eschweiler J, First occurrence of Culicoides obsoletus–transmitted bluetongue virus epidemic in Central Europe. Parasitol Res. 2007;101:219–28.
- Meiswinkel R, van Rijn P, Leijs P, Goffredo M. Potential new Culicoides vector of bluetongue virus in northern Europe. Vet Rec. 2007;161:564–5.
- Gibbs EP, Greiner EC. The epidemiology of bluetongue [review]. Comp Immunol Microbiol Infect Dis. 1994;17:207–20.
- Iben B. Blauzungenkrankheit jetzt auch in Deutschland. Grosstierpraxis. 2006;7:418–27.
- Elbers AR, Backx A, Ekker HM, van der Spek AN, van Rijn PA. Performance of clinical signs to detect bluetongue virus serotype 8 outbreaks in cattle and sheep during the 2006 epidemic in the Netherlands. Vet Microbiol. 2008;129:155–62.
- Toussaint JF, Sailleau C, Mast J, Houdart P, Czaplicki G, Demeestere L, Bluetongue in Belgium, 2006. Emerg Infect Dis. 2007;13:614–6.
- Wilson A, Carpenter S, Gloster J, Mellor P. Re-emergence of bluetongue in northern Europe in 2007. Vet Rec. 2007;161:487–9.
- Landeg F. Bluetongue outbreak in the UK. Vet Rec. 2007;161:534–5.
- Saegerman C, Berkvens D, Mellor PS. Bluetongue epidemiology in the European Union. Emerg Infect Dis. 2008;14:539–44.
- Hofmann M, Griot C, Chaignat V, Perler L, Thür B. Bluetongue disease reaches Switzerland. Schweiz Arch Tierheilkd. 2008;150:49–56.
- Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods. 2007b;140:115–23.
- Gloster J, Mellor PS, Burgin L, Sanders C, Carpenter S. Will bluetongue come on the wind to the United Kingdom in 2007? Vet Rec. 2007;160:422–6.
- Mertens PP, Maan NS, Prasad G, Samuel AR, Shaw AE, Potgieter AC, Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains. J Gen Virol. 2007;88:2811–23.
- Figure. A) Bluetongue virus (BTV) serotype 8 genome in a field sample collected May 3, 2007 (BH95/07), detected by using real-time reverse transcription–PCR with a 6-carboxy fluorescein-labeled probe (FAM). The magnitudes...
- Table. Results of rRT–PCR and bluetongue virus competition ELISA of samples from experimentally inoculated animals
Please use the form below to submit correspondence to the authors or contact them at the following address:
Martin Beer, Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald-Insel Riems, Germany;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 13, 2010
- Page last updated: July 13, 2010
- Page last reviewed: July 13, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)